Butyl chloroformate → HCID 10116525, compound
Reaction equation
[CH2:1]([C:5]1[S:9][C:8]([S:10]([NH2:13])(=[O:12])=[O:11])=[C:7]([C:14]2[CH:19]=[CH:18][C:17]([CH2:20][N:21]3[N:25]=[N:24][CH:23]=[N:22]3)=[CH:16][CH:15]=2)[CH:6]=1)[CH:2]([CH3:4])[CH3:3].N1(C2C=CC=CN=2)CCCC1.Cl[C:38]([O:40][CH2:41][CH2:42][CH2:43][CH3:44])=[O:39].C(C1SC(S(NC(C)(C)C)(=O)=O)=C(C2C=CC(CN3N=NC=N3)=CC=2)C=1)C(C)C>N1C=CC=CC=1>[CH2:41]([O:40][C:38]([NH:13][S:10]([C:8]1[S:9][C:5]([CH2:1][CH:2]([CH3:4])[CH3:3])=[CH:6][C:7]=1[C:14]1[CH:19]=[CH:18][C:17]([CH2:20][N:21]2[N:25]=[N:24][CH:23]=[N:22]2)=[CH:16][CH:15]=1)(=[O:12])=[O:11])=[O:39])[CH2:42][CH2:43][CH3:44]Participants
6
Procedure
The crude product from step (d) above was dissolved in pyridine (1 mL, dried over 4 Å molecular sieve). Pyrrolidinopyridine (14 mg, 0.0095 mmol) and butyl chloroformate (120 μL, 0.97 mmol) were added to the mixture, which was then stirred for 30 hours under N2(g) at room temperature. The solvent was removed in vacuo and then co-evaporated with acetonitrile. Purification using column chromatography with CHCl3:MeOH (35:1) as eluent yielded the title compound (24.9 mg, 0.052 mmol) in 54% yield (from 5-iso-butyl-N-tert-butyl-3-(4-tetrazol-2-ylmethylphenyl)thiophene-2-sulfonamide).
Workup
- customThe solvent was removed in vacuo
- customPurification
Sources & evidence
- ORD record
- ord-ab48aa8eabee4e87a68f06e3f1162a8a
- Source dataset
- uspto-grants-2012_02
- Patent number
- US08124638B2
Reaction notes
Loading…